Ligand profile
CHEMBL1417331
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_4636 — inositol monophosphatase, putative mRNA turnover protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL1417331- UniProt (similar protein)
P97697- pchembl
- 8.400 (~4.0 nM)
- Target protein
- VK055_4636
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 35.0
- −1 ≤ LogP ≤ 5 4.08
- MW ≤ 500 Da 256.7
- LogP ≤ 5 4.08
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 3
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 35.0
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Clc1ccccc1Oc1cnc2ccccc2n1Clc1ccccc1Oc1cnc2ccccc2n1
InChI=1S/C14H9ClN2O/c15-10-5-1-4-8-13(10)18-14-9-16-11-6-2-3-7-12(11)17-14/h1-9HInChI=1S/C14H9ClN2O/c15-10-5-1-4-8-13(10)18-14-9-16-11-6-2-3-7-12(11)17-14/h1-9H
ARCKHELLSLDRAW-UHFFFAOYSA-NARCKHELLSLDRAW-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- Inconclusive
- Binding sites
- PF00459
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL1417331 →
- UniProt UniProt P97697 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL1417331”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4636.
PDB 4
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 99
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).